By Bhanvi Satija LONDON, Oct 30 (Reuters) - Metsera ( MTSR ) has become the obesity drug market's hottest ticket. The New York-based biotech is at the centre of a bidding war between Novo Nordisk and Pfizer ( PFE ), both vying for access to its pipeline of experimental treatments as competition intensifies in the booming $150 billion weight-loss drug...

12:36 PM EDT, 10/30/2025 (MT Newswires) -- Disc Medicine ( IRON ) is positioned for a stronger commercial path following an upsized $250 million equity offering and positive pipeline updates, Morgan Stanley said in a note Wednesday. The firm raised its probability of success for lead drug candidate bitopertin to 85% from 80% and increased its peak market share estimate...

12:31 PM EDT, 10/30/2025 (MT Newswires) -- ServiceNow ( NOW ) reported strong Q3 results that reflected healthy enterprise demand, despite investor fears concerning the company's momentum in the artificial intelligence space, RBC Capital Markets said in a note Thursday. The company reported late Wednesday Q3 adjusted earnings of $4.86 per diluted share, up from $4.82 a year earlier. Revenue...

Oct 30 (Reuters) - A U.S. court reinstated a $185 million verdict over chemical contamination at a Washington state school on Thursday, overturning a lower court's ruling that had set it aside. ...